Hikma Pharmaceuticals PLC (LON:HIK)
London flag London · Delayed Price · Currency is GBP · Price in GBp
2,008.00
+23.00 (1.16%)
Jul 23, 2025, 11:34 AM BST

Hikma Pharmaceuticals Company Description

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

The company operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals.

The Generics segment offers oral, respiratory, and other generic and specialty products for the retail market.

The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management.

It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally.

Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals logo
CountryUnited Kingdom
Founded1978
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees9,500
CEORiad Mishlawi

Contact Details

Address:
1 New Burlington Place
London, W1S 2HR
United Kingdom
Phone44 20 7399 2760
Websitehikma.com

Stock Details

Ticker SymbolHIK
ExchangeLondon Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberGB00B0LCW083
SIC Code2834

Key Executives

NamePosition
Riad Ali MishlawiChief Executive Officer and Director
Engineer Said Samih Taleb DarwazahExecutive Chairman
Mazen Samih Taleb DarwazahExecutive Vice Chairman and President of MENA
Khalid Waleed Hosny Al Nabilsi CPAChief Financial Officer
Patricia BousfieldChief Information Officer
Guy FeatherstoneAssociate Director of Investor Relations
Samuel ParkGeneral Counsel
Bassam Wael Rushdi Kanaan CFA, CPAExecutive Vice President of Corporate Development and M&A
Hussein Omar ArkhaghaChief People Officer
Susan RingdalExecutive Vice President of Strategic Planning and Global Affairs